secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2021-08-05T23:59:59+00:00
Accession:  0001437749-21-018609
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne Q4 FY2021 revenue up 47% to $259M; adjusted EPS $1.87 vs $1.00 YoY
-----------------------------------------------------------------------------

- Q4 organic revenue rose 39% to $259.0M; GAAP EPS $0.37, adjusted EPS $1.87 (vs $1.00 prior year).
- Full-year revenue $931.0M, adjusted EPS $6.75, record operating cash flow $352M.
- Protein Sciences organic +46%, Diagnostics & Genomics +22%; adj. operating margin 38.5% vs 31.1%.
- Board declares $0.32/share quarterly dividend, payable Aug 27, 2021 to holders of record Aug 16, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000143774921018609/0001437749-21-018609-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000143774921018609/tech20210804_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-21-018609

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer